Share Name Share Symbol Market Type Share ISIN Share Description
Byotrol Plc LSE:BYOT London Ordinary Share GB00B0999995 ORDS 0.25P
  Price Change % Change Share Price Shares Traded Last Trade
  0.30 3.99% 7.825 2,990,263 15:50:55
Bid Price Offer Price High Price Low Price Open Price
7.70 7.95 7.975 7.625 7.625
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 6.07 -0.04 0.08 97.8 35
Last Trade Time Trade Type Trade Size Trade Price Currency
17:07:42 O 565,000 7.25 GBX

Byotrol (BYOT) Latest News (2)

More Byotrol News
Byotrol Takeover Rumours

Byotrol (BYOT) Discussions and Chat

Byotrol Forums and Chat

Date Time Title Posts
13/4/202021:14Byotrol (BYOT) One to Watch on Wednesday 2
27/2/201619:04Byotrol:::::::::Cleaning Up45
03/1/201309:22Byotrol - ready to tap a $5.6billion market?3,489

Add a New Thread

Byotrol (BYOT) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Byotrol trades in real-time

Byotrol (BYOT) Top Chat Posts

Byotrol Daily Update: Byotrol Plc is listed in the Chemicals sector of the London Stock Exchange with ticker BYOT. The last closing price for Byotrol was 7.53p.
Byotrol Plc has a 4 week average price of 7.63p and a 12 week average price of 5.08p.
The 1 year high share price is 10.05p while the 1 year low share price is currently 1.52p.
There are currently 442,842,280 shares in issue and the average daily traded volume is 2,054,031 shares. The market capitalisation of Byotrol Plc is £34,652,408.41.
sikhthetech: Slice, "The backdrop of a declining share price due entirely to inst selling is compelling to patient investors." Really, entirely due to II putting into reader's minds and backing up what 1gw said about II need to put their money somewhere, suggesting that Byot is a good place for their money, eh... Obviously the selling has nothing to do with: The share price is higher than last May, before the long slide.. The issues causing the share price slide are still there.. Last May when the share price was lower: 1) Byot were close to signing a 2nd national retailer 2) Byot had the Tesco contract which served them well 3) No one was expecting any accounting irregularities 4) Trial at Target extended to more sites and was expecting even more. etc Now the share price is higher but: 1) 2nd national retailer NEVER SIGNED, WHY? 2) Byot LOST the TESCO CONTRACT, no replacement announced 3) ACCOUNTS NOT QUALIFIED 4) appointed an agency (costing money) in US and STILL seeking partnerships 5) Trial at Target ENDS NEXT month but so far not rolled out to all stores.. etc etc The share price is now significantly higher based on HOPE and without any of those issues, which caused the share price to fall, being resolved. Honest Guv!!!
mudbath: The opinion of 5.8% holder on their investment in Byotrol:- "Amati VCTs had enjoyed growth from a company in a similar sector, Tristel plc, but decided against investing in Byotrol until 2017. According to Dr Jourdan, new management has been turning the business around and there have been several crucial developments: it has developed strong commercial partnerships, it has recently gained FDA approval in the US, and has recently acquired a business that with supply agreements to the NHS, allowing it to sell its alcohol-free hand sanitizers that reduce skin irritation compared to competing alcohol-based products. This brings it in line with Amati’s criteria of having developed a strong market position to fuel its own growth in years to come." It would be interesting should Amati Global take the current low BYOT share price to increase its holding above 5.80 %.
mudbath: Extracted from the Byotrol Interim Results December 17th 2019:- "The team is also working on a number of business development and monetisation opportunities that should improve results for the full year. The board remains confident that the Company is on target to deliver sustainable operating profits. We remain very excited about the business outlook for Byotrol." Although somewhat delayed,the BYOT share price is at last starting to acknowledge the potential for Byotrol to shed its "perennial loser" tag. (Not before time)
mudbath: Are we seeing the potential for a "triple bottom" in the BYOT share price chart? "What Does a Triple Bottom Tell You? The triple bottom chart pattern typically follows a prolonged downtrend where bears are in control of the market. While the first bottom could simply be normal price movement, the second bottom is indicative of the bulls gaining momentum and preparing for a possible reversal. The third bottom indicates that there's strong support in place and bears may capitulate when the price breaks through resistance levels." (Investopedia) If so(in the event of any subsequent reversal in the prolonged downtrend):- "The formation of triple bottom is seen as an opportunity to enter a bullish position."
mudbath: If the fact that MMs are bidding a good premium for a million shares constitutes a bullish signal then we might expect further progress in the BYOT share price. Ghost The main factor that should help the stock over coming months is its apparent woefull undervaluation at the recently upwardly revised 1.80 pence.Any positive future developments will serve to further improve sentiment. As Thunderclap Newman once said (is there),"Something in the Air" ?
sikhthetech: 1gw, "The comparison with tly is relevant because of the similarity of the acquisition model," That's exactly my point and what I was saying... you use 'original contingency to state TLY fell short of expectations', yet on here you refer to potential of BYOT's acquisition.. and in your usual devious way, you change your view and, with your smooth posts, make it seem as if your view hasn't changed...your ego get's in the way, eh? But good to see you finally agree with the acquisition model being similar I mentioned the similarity in the acquisition model on the TLY but then you went quiet after I posted this, strange wasn't it, 1gw? sikhthetech - 07 Jun 2019 - 20:42:42 - 9223 of 10490 Totally Health - 2014 onwards - TLY 1gw, There's this company who specialise in disinfectant cleaners... you may have heard of them... Byotrol (BYOT).. They bought Medimark, nearly a yr ago as follows..: 1) Initial consideration of £2.3m 2) £0.4m Medimark debt 3) £1.15m cash 4) £1.15m from additional shares @ 4.1p 5) £1.8m deferred subject to achieving EBIDTA targets... Total consideration £4.5m for a company making ADJUSTED EBITDA of ONLY £380k on revenues of just £2.7m... using a similar strategy as TLY. "year ended 31 March 2018, Medimark reported adjusted EBITDA of GBP380k on revenues of GBP2.7m." "Consideration of up to GBP4.5m is payable in respect of the Acquisition, which includes GBP0.4m of debt that Byotrol is assuming.. Initial consideration of GBP2.3m is payable on completion, being GBP1.15m in cash and GBP1.15m from 28,048,780 new ordinary shares ("Ordinary Shares") being issued at 4.1p per share. An additional GBP1.8m of consideration is payable subject to achieving EBITDA targets in FYE 31 March 2019 and FYE March 2020. The deferred consideration is also to be paid half in cash and half in new ordinary shares." The placing price @ 4.1p, the current share price is around 50% lower @ 2.1p. Your ONE post on the acquisition, on the day of acquisition announced: 1gw - 23 Aug 2018 - 13:10:33 - 3152 of 3628 BYOTROL-CAN DELIVER AMAZING RESULTS - BYOT Nice surprise on my return from the beach! Good to see them get the results out today in the end and I like the fact that the acquisition shares are priced above 4p. Also I agree it sounds like good news that the Target trial is being extended - although I suppose it could mean the results are borderline and they need more time to decide whether it is going to be viable. Didn't you look at the accounts, liabilities, strategy etc, before loading up... Oh you did. Management seem to be doing the right thing, eh... Management seem to be doing the right things... 1gw - 28 Feb 2019 - 15:04:42 - 3455 of 3628 BYOTROL-CAN DELIVER AMAZING RESULTS - BYOT I've bought some more. Takes Byotrol into the top 3 in my portfolio. High risk, but management seem to be doing the right things and sound confident. I think there is potential for the share price to do very well, especially if they can derisk the US by landing some licensing deals now that they've got such a good shop window through the Target trial.
mudbath: With the chart looking as though the share price might be about to go higher,would anyone venture to hazard a guess at the BYOT share price on BREXIT day or October 31st 2019? I could see 3.75p being achievable.
mudbath: Byotrol 24 continues to churn out remarkable content on its US orientated Facebook pages. Generating a stream of proactive input of this quality takes talent. What an opportunity Byotrol,here in the UK,are passing up by not incorporating these eye catching promotions into their own blogs,twitter feed, etc. At least Medimark are "bigging up" their achievements on an almost daily basis. The BYOT share price looks poised to move significantly higher.
mudbath: A significant 928,089 delayed buy trade underlines my current view that the BYOT share price could well swiftly move above 3 pence and beyond. Byotrol's engagement of Alex Espalin (Ex product launch man at Kimberly-Clark Corporation)looks to be inspired,having regard to the speed with which he has overseen the EPA approval being gained and the introduction of Byotrol 24 across a growing number of TARGET stores,not to mention his stimulating the interest of other retailers in the product. This compares extremely favourably with Tristel's similar US endevours where they have spent 5 YEARS gaining EPA regulatory approval,only to issue the following statement alongside last weeks Interim Results :- "Furthermore, we have decided that our most prudent approach is to postpone commercialising the EPA approvals already obtained for our Duo and Jet products until we have greater visibility of the way ahead for the FDA project."..... "Conferring with consultants, peer companies and industry experts, we are led to believe that we should not be dismayed by the time it has taken to reach the point we are at today; nor by the cumulative cost, which amounted at 31 December 2018 to GBP1.3m." Byotrol/Medimark Scientific look poised to make inroads into Tristel's markets. Happy days !
mudbath: Investing is all about timing and if anyone missed the opportunity to mop up those Ruffer shares @ just 1.50 pence then fear not,for BYOT remain a total steal at today's 2.40 pence to buy.Remember that Medimark Scientific was purchased with Byotrol shares valued at 4.10 pence and with cash,also raised @ 4.0 pence. Listening to the vibes it looks as though BYOT are on something of a roll at the moment,with the market due to be appraised of progress in an upcoming trading update. It seems logical,to me,that the BYOT share price will soon resume its upward trajectory;maybe even in a vigorous fashion. BUY. NOW !!
Byotrol share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200927 05:24:09